EurekaMag.com logo
+ Site Statistics
References:
53,214,146
Abstracts:
29,074,682
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

ROCK and JAK1 signaling cooperate to control actomyosin contractility in tumor cells and stroma


Cancer Cell 20(2): 229-245
ROCK and JAK1 signaling cooperate to control actomyosin contractility in tumor cells and stroma
Proinflammatory cytokines are frequently observed in the tumor microenvironment, and chronic inflammation is involved in cancer initiation and progression. We show that cytokine signaling through the receptor subunit GP130-IL6ST and the kinase JAK1 generates actomyosin contractility through Rho-kinase dependent signaling. This pathway generates contractile force in stromal fibroblasts to remodel the extracellular matrix to create tracks for collective migration of squamous carcinoma cells and provides the high levels of actomyosin contractility required for migration of individual melanoma cells in the rounded, "amoeboid" mode. Thus, cytokine signaling can generate actomyosin contractility in both stroma and tumor cells. Strikingly, actomyosin contractility itself positively modulates activity of the transcription factor STAT3 downstream of JAK1, demonstrating positive feedback within the signaling network.

(PDF same-day service: $19.90)

Accession: 055338095

PMID: 21840487

DOI: 10.1016/j.ccr.2011.06.018



Related references

ROCK-driven actomyosin contractility induces tissue stiffness and tumor growth. Cancer Cell 19(6): 695-697, 2011

Rho, ROCK and actomyosin contractility in metastasis as drug targets. F1000research 5: -, 2016

JAK1 activates STAT3 activity in non-small-cell lung cancer cells and IL-6 neutralizing antibodies can suppress JAK1-STAT3 signaling. Molecular Cancer Therapeutics 10(3): 481-494, 2011

Determinates of tumor response to radiation: tumor cells, tumor stroma and permanent local control. RadioTherapy and Oncology 113(1): 146-149, 2015

Wnt/Frizzled signaling controls C. elegans gastrulation by activating actomyosin contractility. Current Biology 16(20): 1986-1997, 2006

Tumor necrosis factor alpha (TNF-alpha) activates Jak1/Stat3-Stat5B signaling through TNFR-1 in human B cells. Cell Growth & Differentiation 13(1): 13-18, 2002

Jasplakinolide induced axon retraction is mediated by actomyosin contractility and regulated by the tonic activity of the Rho-ROCK pathway. Molecular Biology of the Cell 11(Supplement): 179a, 2000

Protein kinase C activation disrupts epithelial apical junctions via ROCK-II dependent stimulation of actomyosin contractility. Bmc Cell Biology 10(): 36-36, 2009

Non-muscle myosin IIB helps mediate TNF cell death signaling independent of actomyosin contractility (AMC). Journal of Cellular Biochemistry 110(6): 1365-1375, 2010

Inhibition of JAK1, 2/STAT3 signaling induces apoptosis, cell cycle arrest, and reduces tumor cell invasion in colorectal cancer cells. Neoplasia 10(3): 287-297, 2008